Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
The Christ Hospital Health Network, Cincinnati (United States of America)
6 More presentations in this session
Professor J. Vaclavik (Ostrava, CZ)
Doctor A. Stevanovic (Belgrade, RS)
Doctor Z. Yang (Chengdu - Sichuan, CN)
Professor R. Hany Ibrahim (Cairo, EG)
Doctor S. Alexander (Melbourne, AU)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
